[Use of medical apps and online platforms among German rheumatologists : Results of the 2016 and 2018 DGRh conference surveys and research conducted by rheumadocs].
Nutzung von Medizin-Apps und Online-Plattformen unter deutschen Rheumatologen : Ergebnisse der rheumadocs-Recherche und DGRh-Kongress-Umfragen von 2016 und 2018.
Medical apps
Rheumatology
Telemedicine
eHealth
mHealth
Journal
Zeitschrift fur Rheumatologie
ISSN: 1435-1250
Titre abrégé: Z Rheumatol
Pays: Germany
ID NLM: 0414162
Informations de publication
Date de publication:
Nov 2019
Nov 2019
Historique:
pubmed:
14
12
2018
medline:
28
11
2019
entrez:
14
12
2018
Statut:
ppublish
Résumé
Apps and online platforms play an ever increasing role in the daily work routine of physicians. The aim of this study was to investigate which medical apps and online platforms are used by German rheumatologists for certain tasks and to identify usage trends. Data were collected via a SurveyMonkey survey conducted by members of rheumadocs (Young German Rheumatology Association) at the 2016 and 2018 German Society for Rheumatology (DGRh) conferences. In 2016 and 2018 the survey was completed by 75 and 84 assistant and specialist rheumatologists, respectively. In 2016, 37% of rheumatologists were using medical apps in routine care which changed to 49% in 2018. In 2016, 47% compared to 68% in 2018, planned to integrate medical apps into routine care. In total, 20 different medical apps were recommended for colleagues to use; however only 2 of these apps were specific for rheumatology. In contrast to 52 app recommendations for colleagues, only 8 app recommendations for patients were recorded. Most recommendations to physicians received the app "Arznei aktuell" (21%). "Embryotox" was the app, most recommended to patients (38%). In 2016 the online database PubMed was most popular and 97% of participants were familiar with it. Use of other online platforms showed great age dependency in 2016: Amboss (a digital learning platform) was used by 31% of the age group 21-30 years and was not used at all by the age group 51-60 years. Use of medical apps and planned integration of medical apps into routine care is increasing among German rheumatologists. On the other hand, recommendable rheumatological apps for rheumatologists and especially for patients are currently largely unknown to rheumatologists.
Sections du résumé
BACKGROUND
BACKGROUND
Apps and online platforms play an ever increasing role in the daily work routine of physicians. The aim of this study was to investigate which medical apps and online platforms are used by German rheumatologists for certain tasks and to identify usage trends.
METHODS
METHODS
Data were collected via a SurveyMonkey survey conducted by members of rheumadocs (Young German Rheumatology Association) at the 2016 and 2018 German Society for Rheumatology (DGRh) conferences.
RESULTS
RESULTS
In 2016 and 2018 the survey was completed by 75 and 84 assistant and specialist rheumatologists, respectively. In 2016, 37% of rheumatologists were using medical apps in routine care which changed to 49% in 2018. In 2016, 47% compared to 68% in 2018, planned to integrate medical apps into routine care. In total, 20 different medical apps were recommended for colleagues to use; however only 2 of these apps were specific for rheumatology. In contrast to 52 app recommendations for colleagues, only 8 app recommendations for patients were recorded. Most recommendations to physicians received the app "Arznei aktuell" (21%). "Embryotox" was the app, most recommended to patients (38%). In 2016 the online database PubMed was most popular and 97% of participants were familiar with it. Use of other online platforms showed great age dependency in 2016: Amboss (a digital learning platform) was used by 31% of the age group 21-30 years and was not used at all by the age group 51-60 years.
DISCUSSION
CONCLUSIONS
Use of medical apps and planned integration of medical apps into routine care is increasing among German rheumatologists. On the other hand, recommendable rheumatological apps for rheumatologists and especially for patients are currently largely unknown to rheumatologists.
Identifiants
pubmed: 30542914
doi: 10.1007/s00393-018-0578-3
pii: 10.1007/s00393-018-0578-3
doi:
Types de publication
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Pagination
839-846Références
Radiologe. 2017 Sep;57(9):752-759
pubmed: 28707151
Am J Prev Med. 2014 Apr;46(4):404-8
pubmed: 24650843
Br J Gen Pract. 2014 Jul;64(624):e384-91
pubmed: 24982490
BMC Musculoskelet Disord. 2016 Aug 24;17(1):362
pubmed: 27553253
Ann Rheum Dis. 2016 Apr;76(4):712-715
pubmed: 27797750
BMC Med Inform Decis Mak. 2012 Oct 30;12:121
pubmed: 23110712
J Med Internet Res. 2013 Dec 30;15(12):e277
pubmed: 24449711
JMIR Mhealth Uhealth. 2017 Feb 21;5(2):e7
pubmed: 28223263
JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27
pubmed: 25760773
Rheumatol Int. 2018 Nov;38(11):1949-1957
pubmed: 29713795
Ann Rheum Dis. 2018 Jul;77(7):963-965
pubmed: 29802224